Suchergebnisse - "Yao, Hang-Ping"

PubPharm (86)

1

RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells

enthalten in: Current cancer drug targets | 2023

von Suthe, S. | Yao, H. | Weng, T. | +1

2

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

enthalten in: Journal of medical virology | 2023

von Liang, L. | Zhu, M. | He, R. | +12

3

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

4

The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus

enthalten in: Virology journal | 2021

von Wu, X. | Tang, S. | Yao, S. | +7

5

Mechanism of apoptotic induction on T24 cells by honokiol and its synergistic anticancer effect in combination with hydroxycamptothecin

enthalten in: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan | 2021

von Lou, G. | Luo, Y. | Xie, L. | +2

6

Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy : Pharmaceutical strategy and clinical progress

enthalten in: Drug discovery today | 2021

von Yao, H. | Zhao, H. | Hudson, R. | +2

7

Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase

enthalten in: Drug discovery today | 2021

von Yao, H. | Tong, X. | Wang, M.

8

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

9

Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer

enthalten in: Drug discovery today | 2020

von Yao, H. | Suthe, S. | Hudson, R. | +1

10

RON receptor tyrosine kinase in pancreatic ductal adenocarcinoma : Pathogenic mechanism in malignancy and pharmaceutical target for therapy

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

1
2
3
4
5
6
7
8
9
Nächster »
[9]